Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

33.87
+0.02000.06%
Post-market: 33.870.00000.00%19:06 EDT
Volume:1.41M
Turnover:47.66M
Market Cap:6.44B
PE:-11.76
High:34.30
Open:33.54
Low:33.37
Close:33.85
Loading ...

BridgeBio reports open-label extension data on acoramidis in ATTR-CM

TIPRANKS
·
19 Nov 2024

Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months

THOMSON REUTERS
·
19 Nov 2024

BridgeBio Pharma Inc - Acoramidis Well Tolerated With No New Safety Signals in Long-Term Evaluation

THOMSON REUTERS
·
19 Nov 2024

BridgeBio announces publication of PROPEL 2 data in NEJM

TIPRANKS
·
18 Nov 2024

BridgeBio price target raised to $45 from $44 at Scotiabank

TIPRANKS
·
15 Nov 2024

BridgeBio Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
14 Nov 2024

BridgeBio Pharma (BBIO) Gets a Buy from Bank of America Securities

TIPRANKS
·
13 Nov 2024

Evercore ISI Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
13 Nov 2024

U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot

Reuters
·
13 Nov 2024

BridgeBio Pharma Inc : Raymond James Raises Target Price to $48 From $46

THOMSON REUTERS
·
13 Nov 2024

BridgeBio Pharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

BridgeBio Pharma (BBIO) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
12 Nov 2024

BridgeBio Pharma's Q3 Loss Narrows, Revenue Declines

MT Newswires Live
·
12 Nov 2024

BridgeBio Pharma Q3 2024 GAAP EPS $(0.86) Beats $(0.99) Estimate, Sales $2.73M Miss $3.76M Estimate

Benzinga
·
12 Nov 2024

BridgeBio Pharma: Q3 Earnings Snapshot

Associated Press Finance
·
12 Nov 2024

BridgeBio Pharma Inc expected to post a loss of 98 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

BridgeBio announces publication on impact of biomedical innovation

TIPRANKS
·
05 Nov 2024

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks
·
31 Oct 2024

Scotiabank Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
25 Oct 2024

BridgeBio Pharma Price Target Maintained With a $43.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Oct 2024